EUVIMEDEUVIMED entdecken
Open Access

Tumor-responsive cuproptosis nanoinducer realizing efficient PANoptosis for enhanced cancer immunotherapy

Kaiqing Yun, Xiaohong Yu, Shuang Liang, Qingling Wang, Ziyi Zhang, Yue Han, Yueyang Zhao, Yuxuan Peng, Lang Rao, Yong Cui, Zhaohui Wang

Theranostics · 16.08.2025 · 15 (17) · 9294-9305

DOI: 10.7150/thno.115275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 16.08.2025. Verfasst von Kaiqing Yun und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Pek…. Hauptthemen laut MEDLINE: Immunotherapy, Copper, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyCopperNanoparticlesNeoplasmsAnimalsMiceTumor MicroenvironmentCell Line, TumorHumansImmune Checkpoint InhibitorsImmunogenic Cell DeathFemaleMice, Inbred BALB C

Stichwörter der Autor:innen

Cancer immunotherapyCuproptosisNano-inducerPANoptosisRegulated cell deathsTumor-responsive nanoparticles

Substanzen

CopperImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
  • Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
  • College of Medical Devices, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • School of Life Sciences and Biopharmaceutical Science, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Hebei Key Laboratory of Innovative Drug Research and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China.

Zitieren

APA

Yun, K., Yu, X., Liang, S., Wang, Q., Zhang, Z., Han, Y., Zhao, Y., Peng, Y., Rao, L., Cui, Y., & Wang, Z. (2025). Tumor-responsive cuproptosis nanoinducer realizing efficient PANoptosis for enhanced cancer immunotherapy. Theranostics, 15(17), 9294-9305. https://doi.org/10.7150/thno.115275

Vancouver

Yun K, Yu X, Liang S, Wang Q, Zhang Z, Han Y, et al. Tumor-responsive cuproptosis nanoinducer realizing efficient PANoptosis for enhanced cancer immunotherapy. Theranostics. 2025;15(17):9294-9305. doi:10.7150/thno.115275

BibTeX
@article{Yun2025,
  author = {Yun, Kaiqing and Yu, Xiaohong and Liang, Shuang and Wang, Qingling and Zhang, Ziyi and Han, Yue and Zhao, Yueyang and Peng, Yuxuan and Rao, Lang and Cui, Yong and Wang, Zhaohui},
  title = {Tumor-responsive cuproptosis nanoinducer realizing efficient PANoptosis for enhanced cancer immunotherapy},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {17},
  pages = {9294--9305},
  doi = {10.7150/thno.115275}
}
Kostenlos starten →